News for Sino Biopharmaceutical Limited (1177.HK)

- Dual Success of Innovative Drugs and Generic Drugs- Revenue Recorded RMB28.87 Billion- Adjusted non-HKFRS Profit Attributable to the Owners of the Parent Reco

Sino Biopharmaceutical Limited (SBHMY) declares $0.0653/share quarterly dividend, payable Oct. 18 for shareholders of record Sept. 12.

At least 11 generic versions of Novo Nordisk's popular diabetes drug Ozempic are in the final stages of clinical trials in China, as developers seek to profit from an early patent expiry of...

Sino Biopharm (1177.HK) Announces 2023 Annual Results

Enhancing Cancer Patients' Quality of Life: Cancer Chemotherapy-Associated Nausea and Vomiting Therapeutics Market Offers Innovative Solutions to Alleviate...

Strong sales fully demonstrated Akeso's commercialization ability: Products sales totaled RMB1,104.4 million, increasing 422% .开坦尼® (cadonilimab) recorded...

Current national security tensions could put F-star's acquisition by Sino Biopharmaceutical at significant risk. Here's what investors in FSTX stock need to know.

LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- invoX Pharma (“invoX”), a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX...

/PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and...

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | December 29, 2022

Merger arbitrage spreads are still wide. Plenty of opportunities with 10%-75% spreads. Click here to read detailed review of all transactions in the space.

Aktieägarna i Karolinska Development AB (publ), org.nr 556707-5048, (“Karolinska Development” eller “Bolaget”), kallas till årsstämma torsdagen den 12 maj...

/PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the...

HONG KONG, Nov. 23, 2021 /PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong T...

The world's biggest pharmaceutical companies are worth $4.1 trillion. Here we map the top 100 companies based on their market cap value. The post Visualizing the World’s Biggest Pharmaceutical Companies appeared first on Visual Capitalist.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | February 23, 2021